SkinBioTherapeutics PLC

H1 ended 31 December 2024

A heartfelt thank you to all our paid subscribers at Lemming Investor Research Newsletter and its sister publication, Small Company Champion. Together, we’ve now welcomed nearly 2,000 investors across both titles — with Small Company Champion proudly holding "Best Seller" status on Substack, boasting 1,000+ members and growing fast.

And if you’re not yet on board... why not?

This is your chance to stay ahead of the herd — with timely insights, rigorous analysis, and a sharp eye for value. Join the growing community of investors who aren't waiting for the headlines to catch up.

By Elric Langton | 29 March 2025